fda warning on semaglutide Says to Drop Suicide From GLP-1 Drug Labels FDA Adds New Warning to

The findings shed light on the barriers that people with obesity experience in accessing weight-loss treatment in a healthcare system that often views obesity as a risk factor for other diseases that should be managed through lifestyle changes alone

Your body is intelligent

Do not push through severe side effects in silence

Approximate equivalency chart These are rough guidelines based on clinical observation, not precise conversions: Semaglutide 0.25-0.5mg corresponds roughly to tirzepatide 2.5-5mg Semaglutide 1mg corresponds roughly to tirzepatide 5-7.5mg Semaglutide 1.7mg corresponds roughly to tirzepatide 7.5-10mg Semaglutide 2.4mg corresponds roughly to tirzepatide 10-15mg These equivalencies suggest where you might eventually land, not where you should start

It mimics a naturally occurring hormone called glucagon-like peptide-1 (GLP-1), which signals your brain that youre full and slows stomach emptying